Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Location » New Zealand

Wellington, New Zealand Clinical Trials

Alzheimer's Disease

Merck Sharp & Dohme (New Zealand) Ltd.,

Patients are needed to participate in a clinical research study of MK-8931 and Placebo to evaluate Alzheimer's Disease

Merck Sharp & Dohme (New Zealand) Ltd.,

Patients are needed to participate in a clinical research study of MK-8931 and Placebo to evaluate Amnestic Mild Cognitive Impairment, Alzheimer's Disease or Prodromal Alzheimer's Disease

Anemia

CTI Investigative Site 64004 Updated

A clinical trial to evaluate treatments using Pacritinib and Best Available Therapy for patients with Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis or Post-essential Thrombocythemia Myelofibrosis

Arthritis and Arthritic Pain

Research Site

A clinical research study of IPI-145 and Placebo for the treatment of Rheumatoid Arthritis

Research Site Updated

A clinical research study for the treatment of Arthritis, Rheumatoid

1301.1.3407 Boehringer Ingelheim Investigational Site

A clinical trial to evaluate treatments for patients with Arthritis, Rheumatoid

Asthma

Research Site Updated

A clinical research study of lebrikizumab and placebo for the treatment of Asthma

Atrial Fibrillation

Wellington Hospital

A clinical study for patients with Heart Failure or Atrial Fibrillation

Bronchiectasis

Research Site

A clinical trial seeking patients for a research study for the treatment of Bronchiectasis

Constipation

Research Site Updated

Patients are needed to participate in a clinical research study of Placebo and Linaclotide to evaluate Irritable Bowel Syndrome With Constipation (IBS-C)

COPD (Chronic Obstructive Pulmonary Disease)

GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

P3 Research Updated

Patients are needed to participate in a clinical research study of AQX-1125 and Placebo to evaluate COPD

Crohn's Disease

WaiKato Hospital Updated

A Phase 2 clinical study for patients with Crohn's Disease

Cytomegalovirus Infections

Merck Sharp & Dohme (New Zealand) Ltd., Updated

A Phase 3 clinical study for patients with Cytomegalovirus Infections

Deep Vein Thrombosis

Research Site Updated

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Diabetes Mellitus, Type 1

Merck Sharp & Dohme (New Zealand) Ltd.,

A clinical research study of MK-1293, Lantus™ and Prandial Insulin for the treatment of Type 1 Diabetes Mellitus

Diabetes Mellitus, Type 2

Research Site

A clinical research study of Placebo, Canagliflozin, 100 mg and Canagliflozin, 300 mg for the treatment of Diabetes Mellitus, Type 2 or Albuminuria

Merck Sharp & Dohme (New Zealand) Ltd.,

A clinical trial seeking patients for a research study for the treatment of Diabetes Mellitus, Type 2

Merck Sharp & Dohme (New Zealand) Ltd.,

A clinical trial to evaluate treatments using Sitagliptin, Metformin, Placebo to sitagliptin and Placebo to metformin for patients with Diabetes Mellitus or Type 2 Diabetes

Merck Sharp & Dohme (New Zealand) Ltd.,

A clinical research study for the treatment of Type 2 Diabetes Mellitus

Merck Sharp & Dohme (New Zealand) Ltd., Updated

Patients are needed to participate in a clinical research study evaluating MK-3102 and Placebo for the treatment of Type 2 Diabetes Mellitus

View More »

Merck Sharp & Dohme (New Zealand) Ltd., Updated

A clinical trial seeking patients for a research study for the treatment of Type 2 Diabetes Mellitus

Merck Sharp & Dohme (New Zealand) Ltd., Updated

A clinical research study for the treatment of Type 2 Diabetes Mellitus

Merck Sharp & Dohme (New Zealand) Ltd.,

Patients are needed to participate in a clinical research study of MK-1293 and Lantus™ to evaluate Type 2 Diabetes Mellitus

Endometriosis

Site Reference ID/Investigator# 96060 Updated

A Phase 3 clinical study for patients with Endometriosis

Heart Attack (Myocardial Infarction)

Wellington Hospital Updated

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Heart Failure

Merck Sharp & Dohme (New Zealand) Ltd.,

A clinical research study of MK-7145 2 mg, MK-7145 8 mg, Furosemide and Torsemide for the treatment of Renal Impairment or Heart Failure

Wellington Hospital

A clinical study for patients with Heart Failure or Atrial Fibrillation

Hepatitis

Merck Sharp & Dohme (New Zealand) Ltd.,

Patients are needed to participate in a clinical research study of MK-8408 to evaluate Hepatitis C Infection

Merck Sharp & Dohme (New Zealand) Ltd., Updated

Patients are needed to participate in a clinical research study evaluating MK-5172 100 mg/MK-8742 50 mg FDC tablets and Placebo to MK-5172 100 mg/MK-8742 50 mg FDC tablets for the treatment of Chronic Hepatitis C

High Cholesterol (Hyperlipidemia)

Wellington Hospital Updated

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Inflammatory Bowel Disease

Aotea Pathology (Local Lab)

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Bowen Hospital

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

P3 Research Limited

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Pacific Radiology (X-rays only)

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Lung Disease

GSK Investigational Site

A clinical research study of fluticasone furoate (FF), vilanterol (VI) and umeclidinium bromide (UMEC) for the treatment of Pulmonary Disease, Chronic Obstructive

Lupus

GSK Investigational Site

A Phase 4 clinical study for patients with Systemic Lupus Erythematosus

Malignant Melanoma

Research Site Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Melanoma

Research Site Updated

A clinical trial seeking patients for a research study for the treatment of Malignant Melanoma

Multiple Myeloma

Wellington Hospital

A Phase 3 clinical study for patients with Multiple Myeloma

Wellington Regional Hospital Updated

A clinical trial to evaluate treatments using MLN9708 + Lenalidomide + Dexamethasone and Placebo + Lenalidomide + Dexamethasone for patients with Relapsed Multiple Myeloma or Refractory Multiple Myeloma

Myelofibrosis

CTI Investigative Site 64004 Updated

A clinical trial to evaluate treatments using Pacritinib and Best Available Therapy for patients with Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis or Post-essential Thrombocythemia Myelofibrosis

Neoplasms

Research Site

A clinical research study of Trabectedin, DOXIL and Dexamethasone for the treatment of Ovarian Neoplasms, Peritoneal Neoplasms or Fallopian Tube Neoplasms

Non-Small Cell Lung Cancer

Site Reference ID/Investigator# 125755 Updated

Patients are needed to participate in a clinical research study of veliparib, carboplatin, paclitaxel and placebo to evaluate Squamous Non-Small Cell Lung Cancer

Peripheral Vascular Disease

Wellington Hospital Updated

Patients are needed to participate in a clinical research study of Zilver® PTX® Drug-Eluting Peripheral Stent to evaluate Peripheral Vascular Disease

Pulmonary Embolism

Research Site Updated

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Rheumatoid Arthritis

Research Site

A clinical research study of IPI-145 and Placebo for the treatment of Rheumatoid Arthritis

Research Site Updated

A clinical research study for the treatment of Arthritis, Rheumatoid

1301.1.3407 Boehringer Ingelheim Investigational Site

A clinical trial to evaluate treatments for patients with Arthritis, Rheumatoid

Stroke

Wellington Hospital Updated

A clinical research study of PF-04950615 and Placebo for the treatment of Cardiovascular Disease

Systemic Lupus Erythematosus

GSK Investigational Site

A Phase 4 clinical study for patients with Systemic Lupus Erythematosus

Thromboembolism

Research Site Updated

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Thrombosis

Research Site Updated

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Ulcerative Colitis

Aotea Pathology (Local Lab)

A clinical research study of tofacitinib and Placebo for the treatment of Ulcerative Colitis

Aotea Pathology (Local Lab)

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Bowen Hospital

A clinical research study of tofacitinib and Placebo for the treatment of Ulcerative Colitis

Bowen Hospital Updated

Patients are needed to participate in a clinical research study of CP-690,550 to evaluate Ulcerative Colitis

Bowen Hospital

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

View More »

P3 Research Limited

A clinical research study of tofacitinib and Placebo for the treatment of Ulcerative Colitis

P3 Research Limited Updated

Patients are needed to participate in a clinical research study of CP-690,550 to evaluate Ulcerative Colitis

P3 Research Limited

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Pacific Radiology (X-rays only) Updated

Patients are needed to participate in a clinical research study of CP-690,550 to evaluate Ulcerative Colitis

Pacific Radiology (X-rays only)

A clinical research study of tofacitinib and Placebo for the treatment of Ulcerative Colitis

Pacific Radiology (X-rays only)

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Ulcers

Aotea Pathology (Local Lab)

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Aotea Pathology (Local Lab)

A clinical research study of tofacitinib and Placebo for the treatment of Ulcerative Colitis

Bowen Hospital

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Bowen Hospital

A clinical research study of tofacitinib and Placebo for the treatment of Ulcerative Colitis

Bowen Hospital Updated

Patients are needed to participate in a clinical research study of CP-690,550 to evaluate Ulcerative Colitis

View More »

P3 Research Limited

A clinical research study of tofacitinib and Placebo for the treatment of Ulcerative Colitis

P3 Research Limited

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

P3 Research Limited Updated

Patients are needed to participate in a clinical research study of CP-690,550 to evaluate Ulcerative Colitis

Pacific Radiology (X-rays only) Updated

Patients are needed to participate in a clinical research study of CP-690,550 to evaluate Ulcerative Colitis

Pacific Radiology (X-rays only)

A clinical research study of Placebo and CP690,550 for the treatment of Ulcerative Colitis

Pacific Radiology (X-rays only)

A clinical research study of tofacitinib and Placebo for the treatment of Ulcerative Colitis

Vascular Diseases

Merck Sharp & Dohme (New Zealand) Ltd., Updated

A clinical trial seeking patients for a research study for the treatment of Type 2 Diabetes Mellitus

Wellington Hospital Updated

Patients are needed to participate in a clinical research study of Zilver® PTX® Drug-Eluting Peripheral Stent to evaluate Peripheral Vascular Disease

Venous Thromboembolism

Research Site Updated

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)

Venous Thrombosis

Research Site Updated

A clinical research study of BAY 59-7939 and ASA in the Long-term Prevention of Recurrent Symptomatic VTE (Venous Thromboembolism)